[go: up one dir, main page]

CN102964587A - Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with proline - Google Patents

Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with proline Download PDF

Info

Publication number
CN102964587A
CN102964587A CN2012104460857A CN201210446085A CN102964587A CN 102964587 A CN102964587 A CN 102964587A CN 2012104460857 A CN2012104460857 A CN 2012104460857A CN 201210446085 A CN201210446085 A CN 201210446085A CN 102964587 A CN102964587 A CN 102964587A
Authority
CN
China
Prior art keywords
proline
pro
ester
peg
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012104460857A
Other languages
Chinese (zh)
Inventor
熊玉春
李志成
罗宇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan University of Technology
Original Assignee
Henan University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan University of Technology filed Critical Henan University of Technology
Priority to CN2012104460857A priority Critical patent/CN102964587A/en
Publication of CN102964587A publication Critical patent/CN102964587A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明公开了一种末端连接脯氨酸的聚乙二醇的酸或活性酯的制法和应用,该发明应用于医药领域。此聚合物活性酯在水中水解半衰期为10.9分钟,具有理想的与生物活性物质的氨基反应的活性。其结构式如下:R1-(OCH2CH2)n-O-R2其中n=43~680;R1可以是CH3-,也可以是R2R2的结构如下:

Figure 2012104460857100004DEST_PATH_IMAGE001
R3可以是H-,也可以是-N-丁二酰亚胺基。The invention discloses a preparation method and application of polyethylene glycol acid or active ester whose end is connected with proline, and the invention is applied in the field of medicine. The polymer active ester has a hydrolysis half-life of 10.9 minutes in water, and has an ideal activity of reacting with amino groups of biologically active substances. Its structural formula is as follows: R 1 -(OCH 2 CH 2 ) n -OR 2 where n=43~680; R 1 can be CH 3 - or R 2 The structure of R 2 is as follows:
Figure 2012104460857100004DEST_PATH_IMAGE001
R 3 may be H- or -N-succinimide.

Description

末端连接脯氨酸的聚乙二醇的酸或活性酯的制法和应用Preparation method and application of acid or active ester of polyethylene glycol connected to proline at the end

技术领域 technical field

本发明涉及聚乙二醇水溶性聚合物及其制备方法和应用,尤其涉及聚乙二醇活性酯及其制备方法和应用。 The invention relates to a polyethylene glycol water-soluble polymer and a preparation method and application thereof, in particular to a polyethylene glycol active ester and a preparation method and application thereof.

背景技术 Background technique

使用化学方法将水溶性聚合物聚乙二醇(Polyethylene Glycol,PEG)结合到分子和表面在生物技术中具有重大的应用意义。PEG在生物技术领域有着广泛的应用:一些PEG的活性衍生物结合到蛋白质、酶的分子上,即对酶进行修饰,由于PEG可以溶于有机溶剂,PEG结合到酶分子可以使PEG与酶的结合物溶于有机溶剂;与未修饰的蛋白质相比,将PEG连接到蛋白质上可减小蛋白的免疫原性、降低肾脏排除速率,并可从中促使结合物在血液循环中的半衰期的增加;PEG结合到表面可减小蛋白质和细胞的吸附并改变表面的带电性质,PEG结合到脂质体上可以使其半衰期有极大增加,并能够增加其作为药物缓释的介质的能力。 The use of chemical methods to bind the water-soluble polymer polyethylene glycol (PEG) to molecules and surfaces has significant applications in biotechnology. PEG has a wide range of applications in the field of biotechnology: some active derivatives of PEG are bound to proteins and enzyme molecules, that is, enzymes are modified. Since PEG can be dissolved in organic solvents, PEG combined with enzyme molecules can make PEG and enzyme molecules The conjugate is soluble in organic solvents; compared with unmodified protein, linking PEG to the protein can reduce the immunogenicity of the protein, reduce the rate of renal elimination, and thereby increase the half-life of the conjugate in blood circulation; The binding of PEG to the surface can reduce the adsorption of proteins and cells and change the charged properties of the surface. The binding of PEG to liposomes can greatly increase its half-life and increase its ability as a medium for drug sustained release.

PEG只有经过活化才能够结合到分子或表面上。因此,一系列的活化衍生物被制备出来。目前应用较广的修饰剂活化类型为羧酸的活化酯类。该类修饰剂是通过活化酯对蛋白的自由氨基进行酰化,从而将PEG链结合到蛋白质分子上实现修饰的。 PEG can only bind to molecules or surfaces after activation. Therefore, a series of activated derivatives were prepared. At present, the widely used modifier activation type is the activated ester of carboxylic acid. This type of modifier is modified by activating the ester to acylate the free amino group of the protein, thereby binding the PEG chain to the protein molecule.

目前,许多用于修饰的活化的羧基PEG具有较差的反应活性。例如,羧甲基化PEG(CM-PEG)的NHS酯的反应活性太强,以至溶解在水中立刻水解(在pH8、25°C下的水解半衰期为0.75 min),这种高反应活性是羧甲基化PEG活性酯的严重缺陷。而第一代修饰剂中活化的SC-PEG虽然有较好的反应活性(在pH8、25°C下的半衰期为20.4 min),但由于在分子内含有不稳定的酯键,现已较少使用。又如丁二酸酐丁二酰亚胺酯活化的PEG(succinimidyl succinate,SS-PEG)。SS-PEG的制备是通过mPEG与丁二酸酐发生酯化反应,使丁二酸酐开环,从而在PEG的链端造成一个羧基,然后又将羧基活化成丁二酰亚胺酯。该试剂在与蛋白质结合后还存在一个酯键,而酯键由于其固有的不稳定性在PEG高分子结合到蛋白质上时非常容易被水解。这种水解不仅会使PEG链从蛋白上脱落,丧失PEG修饰带来的益处,而且留在蛋白质上的丁二酸尾部还可作为半抗原导致蛋白质的免疫原性。Harris等人在mPEG的末端引入丙酸单位,使得这种丙酸PEG活性酯的水解半衰期增加到16.5分钟,但该方法涉及了在PEG一端引入氰基,需要再进行强酸和强碱的水解才能得到产物,极有可能破坏PEG主链。 Currently, many activated carboxy-PEGs used for modification have poor reactivity. For example, the NHS ester of carboxymethylated PEG (CM-PEG) is so reactive that it hydrolyzes immediately upon dissolution in water (hydrolysis half-life of 0.75 min at pH 8, 25°C), and this high reactivity is A serious drawback of methylated PEG active esters. Although the activated SC-PEG in the first generation of modifiers has better reactivity (half-life of 20.4 min at pH 8, 25°C), due to the unstable ester bond in the molecule, it is now less use. Another example is PEG (succinimidyl succinate, SS-PEG) activated by succinic anhydride succinimide ester. The preparation of SS-PEG is through the esterification reaction between mPEG and succinic anhydride to open the ring of succinic anhydride, thereby forming a carboxyl group at the chain end of PEG, and then activating the carboxyl group into succinimide ester. The reagent still has an ester bond after it is bound to the protein, and the ester bond is very easily hydrolyzed when the PEG polymer is bound to the protein due to its inherent instability. This hydrolysis will not only detach the PEG chain from the protein and lose the benefits of PEG modification, but also the succinic acid tail left on the protein can act as a hapten to cause the immunogenicity of the protein. Harris et al. introduced propionate units at the end of mPEG, which increased the hydrolysis half-life of this propionate PEG active ester to 16.5 minutes, but this method involved the introduction of a cyano group at one end of PEG, which required further hydrolysis with strong acid and strong base. Obtained products are very likely to destroy the PEG main chain.

目前,许多用于修饰的活化的羧基PEG具有很差的反应活性:不是反应太快就是反应太慢。例如,羧甲基化PEG(CM-PEG)的NHS酯的反应活性太强,以至溶解在水中立刻水解,这种高反应活性是羧甲基化PEG活性酯的严重缺陷。 Currently, many activated carboxyl PEGs used for modification have poor reactivity: they either react too quickly or react too slowly. For example, the NHS ester of carboxymethylated PEG (CM-PEG) is so reactive that it hydrolyzes immediately upon dissolution in water, and this high reactivity is a serious drawback of the active ester of carboxymethylated PEG.

发明内容 Contents of the invention

本发明需要解决的技术问题是公开一种末端连接脯氨酸的聚乙二醇的酸或活性酯的制法和应用,以克服现有技术存在的缺陷,满足医药领域和生物工程领域发展的需要。 The technical problem to be solved in the present invention is to disclose a preparation method and application of a polyethylene glycol acid or active ester connected to proline at the end, so as to overcome the defects in the prior art and meet the development needs of the fields of medicine and bioengineering need.

本发明的末端连接脯氨酸的聚乙二醇的活性酸或酯的结构式如下: The structural formula of the active acid or ester of polyethylene glycol whose end is connected to proline of the present invention is as follows:

R1-(OCH2CH2)n-O-R2 R 1 -(OCH 2 CH 2 ) n -O-R 2

其中n=43~680; where n=43~680;

R1可以是CH3-,也可以是R2 R 1 can be CH 3 - or R 2

R2的结构如下: The structure of R2 is as follows:

Figure 2012104460857100002DEST_PATH_IMAGE001
Figure 2012104460857100002DEST_PATH_IMAGE001

R3可以是H-,也可以是-N-丁二酰亚胺基。 R 3 may be H- or -N-succinimide.

本发明提供的连接脯氨酸的聚乙二醇的活性酯具有合适的反应活性,活性酯在水中的水解半衰期为10.9分钟,且不含有其它的酯键连接。 The active ester of polyethylene glycol linked to proline provided by the invention has suitable reactivity, the hydrolysis half-life of the active ester in water is 10.9 minutes, and does not contain other ester linkages.

本发明的连接脯氨酸的聚乙二醇的活性酯的制备方法包括如下步骤: The preparation method of the active ester of polyethylene glycol linked to proline of the present invention comprises the steps:

(1)CM-PEG(羧甲基化聚乙二醇)的制备: (1) Preparation of CM-PEG (carboxymethylated polyethylene glycol):

将聚乙二醇溶于甲苯中,加入叔丁醇钾回流反应1~2小时,加入溴乙酸乙酯回流反应2~4小时,然后室温反应18~24小时,浓缩后用乙醚沉淀,沉淀物碱水解然后酸化,采用常规的方法收集产物; Dissolve polyethylene glycol in toluene, add potassium tert-butoxide to reflux for 1-2 hours, add ethyl bromoacetate to reflux for 2-4 hours, then react at room temperature for 18-24 hours, concentrate and precipitate with ether, the precipitate Alkaline hydrolysis and then acidification, using conventional methods to collect the product;

(2)脯氨酸乙酯盐酸盐的制备: (2) Preparation of proline ethyl ester hydrochloride:

将氯化氢气体通入含有脯氨酸的乙醇直到饱和,然后收集脯氨酸乙酯盐酸盐; Pass hydrogen chloride gas into ethanol containing proline until saturated, then collect proline ethyl ester hydrochloride;

(3)末端连接脯氨酸的聚乙二醇酸衍生物的制备: (3) Preparation of polyethylene glycol acid derivatives with proline connected at the end:

取步骤(1)中制备的CM-PEG溶于二氯甲烷,然后依次加入二环己基碳二亚胺、脯氨酸乙酯盐酸盐,然后用三乙胺将溶液的pH值调节到8~9,反应8~12小时,过滤,滤液加入乙醚,收集沉淀产物,将产物干燥后溶于水,加入氢氧化钠溶液调节pH至10~12,反应1~3小时,然后用草酸将溶液pH调节到2~4,收集产物,获得末端连接脯氨酸的聚乙二醇酸衍生物。 Take the CM-PEG prepared in step (1) and dissolve it in dichloromethane, then add dicyclohexylcarbodiimide and proline ethyl ester hydrochloride in sequence, and then adjust the pH value of the solution to 8 with triethylamine ~9, react for 8~12 hours, filter, add diethyl ether to the filtrate, collect the precipitated product, dry the product and dissolve it in water, add sodium hydroxide solution to adjust the pH to 10~12, react for 1~3 hours, and then dilute the solution with oxalic acid The pH was adjusted to 2-4, and the product was collected to obtain a polyethylene glycol acid derivative whose end was linked to proline.

(4)取步骤(3)的产物溶于二氯甲烷,加入1.5~3倍摩尔量的二环己基碳二亚胺和1.5~3倍摩尔量的N-羟基丁二酰亚胺,10~30℃搅拌反应20~28小时,收集产物,获得末端连接脯氨酸的聚乙二醇活性酯。 (4) Dissolve the product of step (3) in dichloromethane, add 1.5 to 3 times the molar amount of dicyclohexylcarbodiimide and 1.5 to 3 times the molar amount of N-hydroxysuccinimide, 10 to 3 times the molar amount The reaction was stirred at 30°C for 20-28 hours, and the product was collected to obtain a polyethylene glycol active ester whose end was linked to proline.

所说的脯氨酸为D型、L型或外消旋体; Said proline is D-form, L-form or racemate;

聚乙二醇优选的分子量为2000~30000 Da。 The preferred molecular weight of polyethylene glycol is 2000~30000 Da.

本发明的末端连接脯氨酸的聚乙二醇的活性酯,在水中拥有10.9分钟的水解半衰期,具有理想的与生物活性物质氨基的反应活性,可用于与生物活性物质相连接,制备PEG修饰的生物活性物质,用于制备缓释药物的介质等。 The active ester of polyethylene glycol whose end is connected to proline has a hydrolysis half-life of 10.9 minutes in water, has ideal reactivity with the amino group of biologically active substances, and can be used to link with biologically active substances to prepare PEG modification Biologically active substances, media for the preparation of sustained-release drugs, etc.

本发明还涉及一种所说的末端连接脯氨酸的聚乙二醇活性酸或酯与生物活性物质的结合物,结构通式如下: The present invention also relates to a combination of said polyethylene glycol active acid or ester connected to proline at the end and a biologically active substance, the general structural formula of which is as follows:

Figure 742301DEST_PATH_IMAGE002
Figure 742301DEST_PATH_IMAGE002

其中:n为1或2,NH-Pro部分代表生物活性物质的氨基位点。 Wherein: n is 1 or 2, and the NH-Pro part represents the amino site of the biologically active substance.

生物活性物质选自蛋白质、酶、多肽、药物、染料、核苷、酯类或脂质体。 Biologically active substances are selected from proteins, enzymes, polypeptides, drugs, dyes, nucleosides, esters or liposomes.

采用上述方法制备的末端连接脯氨酸的聚乙二醇活性酯,具有良好的反应活性,可用于与蛋白质或酶的分子相连接,以及用于制备缓释药物的介质。 The proline-linked polyethylene glycol active ester prepared by the above method has good reactivity and can be used for linking with protein or enzyme molecules and for preparing a medium for slow-release medicine.

具体实施方式 Detailed ways

实施例1 Example 1

与分子量为5000 Da的单甲氧基PEG以酰胺键连接的脯氨酸活性酯的合成 Synthesis of proline active ester linked with monomethoxy PEG with a molecular weight of 5000 Da via amide bond

步骤1:CM-PEG(羧甲基化聚乙二醇)的制备: Step 1: Preparation of CM-PEG (Carboxymethylated Polyethylene Glycol):

将分子量为5000 Da的单甲氧基聚乙二醇15 g(3 mmol)溶于甲苯中,蒸馏出一部分甲苯以共沸除水,然后加入4 mmol的叔丁醇钾回流反应1.5小时,而后缓慢加入4 mmol的溴乙酸乙酯回流反应3小时,然后室温反应21小时,过滤除去沉淀后减压蒸去溶剂,残留物加少量二氯甲烷溶解,用干燥乙醚沉淀出产物,将该产物溶于去离子水中,加入0.1 mol/L的氢氧化钠溶液直到溶液的pH值稳定在pH10,然后用0.1 mol/L的盐酸调节溶液的pH到3,用等量的氯仿萃取溶液三次,合并有机相并用无水硫酸钠干燥,浓缩后用乙醚沉淀干燥得到分子量为5000 Da的CM-PEG,分子式如下:CH3O-(CH2CH2O)n-CH2COOH。 Dissolve 15 g (3 mmol) of monomethoxypolyethylene glycol with a molecular weight of 5000 Da in toluene, distill off part of the toluene to remove water azeotropically, then add 4 mmol of potassium tert-butoxide to reflux for 1.5 hours, and then Slowly add 4 mmol of ethyl bromoacetate to reflux reaction for 3 hours, then react at room temperature for 21 hours, remove the precipitate by filtration, evaporate the solvent under reduced pressure, dissolve the residue with a small amount of dichloromethane, precipitate the product with dry ether, dissolve the product In deionized water, add 0.1 mol/L sodium hydroxide solution until the pH value of the solution is stable at pH 10, then adjust the pH of the solution to 3 with 0.1 mol/L hydrochloric acid, extract the solution three times with an equal amount of chloroform, and combine the organic The phases were combined and dried with anhydrous sodium sulfate, concentrated and then precipitated and dried with ether to obtain CM-PEG with a molecular weight of 5000 Da, the molecular formula is as follows: CH 3 O-(CH 2 CH 2 O) n -CH 2 COOH.

步骤2:脯氨酸乙酯盐酸盐的制备: Step 2: Preparation of proline ethyl ester hydrochloride:

将20 g 脯氨酸加入到300 mL无水乙醇中,在搅拌下通入干燥的氯化氢气体直到饱和,然后加入无水乙醇进行减压蒸馏,将多余的氯化氢除去,接着将溶液浓缩至合适的体积,用干燥无水的乙醚沉淀得到脯氨酸乙酯盐酸盐。 Add 20 g of proline to 300 mL of absolute ethanol, pass in dry hydrogen chloride gas under stirring until saturated, then add absolute ethanol for vacuum distillation to remove excess hydrogen chloride, and then concentrate the solution to a suitable volume, and precipitated with dry anhydrous ether to obtain proline ethyl ester hydrochloride.

步骤3:合成以酰胺键连接的mPEG-脯氨酸缀合物: Step 3: Synthesis of mPEG-proline conjugate linked by amide linkage:

取7.5 g(1.5 mmol)步骤(1)中制备的CM-PEG溶于40 mL干燥的二氯甲烷中,然后依次加入2 mmol的二环己基碳二亚胺、2 mmol的脯氨酸乙酯盐酸盐,然后用三乙胺将溶液的pH值调节到8,搅拌反应12小时,过滤除去沉淀后,加入无水乙醚沉淀产物,将产物干燥后溶于去离子水,加入0.1 mol/L氢氧化钠溶液调节pH至11,反应2小时,然后用草酸将溶液pH调节到3,用氯仿萃取溶液三次,合并萃取液用无水硫酸钠干燥,溶液浓缩后再用无水乙醚沉淀得到分子量为5000 Da的以酰胺键连接的mPEG-脯氨酸缀合物。 Take 7.5 g (1.5 mmol) of CM-PEG prepared in step (1) and dissolve in 40 mL of dry dichloromethane, then add 2 mmol of dicyclohexylcarbodiimide and 2 mmol of ethyl proline Hydrochloride, then adjust the pH value of the solution to 8 with triethylamine, stir for 12 hours, filter to remove the precipitate, add anhydrous ether to precipitate the product, dry the product and dissolve it in deionized water, add 0.1 mol/L Sodium hydroxide solution adjusted the pH to 11, reacted for 2 hours, then adjusted the pH of the solution to 3 with oxalic acid, extracted the solution three times with chloroform, combined the extracts and dried them with anhydrous sodium sulfate, concentrated the solution and then precipitated with anhydrous ether to obtain the molecular weight 5000 Da amide-linked mPEG-proline conjugate.

步骤4: Step 4:

取步骤3制备的分子量为5000 Da的mPEG-脯氨酸,溶于干燥精制的无水二氯甲烷中,加入1.2倍摩尔量的二环己基碳二亚胺(DCC)和1.2倍摩尔量的N-羟基丁二酰亚胺,室温搅拌反应24小时,停止反应滤除沉淀二环己基脲(DCU),溶液用无水乙醚沉淀得到产物分子量为5000 Da的mPEG-脯氨酸的N-羟基丁二酰亚胺酯。 Take the mPEG-proline with a molecular weight of 5000 Da prepared in step 3, dissolve it in dry and refined anhydrous dichloromethane, add 1.2 times the molar amount of dicyclohexylcarbodiimide (DCC) and 1.2 times the molar amount of N-hydroxysuccinimide, stirred at room temperature for 24 hours, stopped the reaction and filtered off the precipitated dicyclohexyl urea (DCU), and the solution was precipitated with anhydrous ether to obtain the N-hydroxyl group of mPEG-proline with a molecular weight of 5000 Da Succinimide ester.

实施例2 Example 2

与分子量为20000 Da的PEG二酸以酰胺键连接的脯氨酸活性酯的合成 Synthesis of proline active ester linked with PEG diacid with molecular weight of 20000 Da by amide bond

步骤1:CM-PEG二酸的制备: Step 1: Preparation of CM-PEG diacid:

将分子量为20000 Da的单甲氧基聚乙二醇20 g(1 mmol)溶于适量的甲苯中,蒸馏出一部分甲苯以共沸除水,然后加入3 mmol的叔丁醇钾回流反应2小时,而后缓慢加入3 mmol的溴乙酸乙酯回流反应4小时,然后室温反应18小时,过滤除去沉淀后减压蒸去溶剂,残留物加入二氯甲烷溶解,用干燥乙醚沉淀出产物,将该产物溶于去离子水中,逐渐加入0.1 mol/L的氢氧化钠溶液直到溶液的pH值稳定在pH10,然后用0.1 mol/L的盐酸调节溶液的pH到3,用等量的氯仿萃取溶液三次,合并有机相并用无水硫酸钠干燥,浓缩后用乙醚沉淀干燥得到分子量为20000 Da的CM-PEG二酸,化学式如下:HOOCCH2O-(CH2CH2O)n-CH2COOH。 Dissolve 20 g (1 mmol) of monomethoxypolyethylene glycol with a molecular weight of 20,000 Da in an appropriate amount of toluene, distill a part of the toluene to remove water azeotropically, and then add 3 mmol of potassium tert-butoxide to reflux for 2 hours , and then slowly add 3 mmol of ethyl bromoacetate to reflux reaction for 4 hours, then react at room temperature for 18 hours, filter and remove the precipitate, evaporate the solvent under reduced pressure, add dichloromethane to the residue to dissolve, and precipitate the product with dry ether. Dissolve in deionized water, gradually add 0.1 mol/L sodium hydroxide solution until the pH value of the solution is stable at pH 10, then adjust the pH of the solution to 3 with 0.1 mol/L hydrochloric acid, extract the solution three times with an equal amount of chloroform, The organic phases were combined and dried with anhydrous sodium sulfate, concentrated and then precipitated and dried with ether to obtain a CM-PEG diacid with a molecular weight of 20000 Da. The chemical formula is as follows: HOOCCH 2 O-(CH 2 CH 2 O) n -CH 2 COOH.

步骤2:脯氨酸乙酯盐酸盐的制备: Step 2: Preparation of proline ethyl ester hydrochloride:

将20 g 脯氨酸加入到300 mL无水乙醇中,在搅拌下通入干燥的氯化氢气体直到饱和,然后加入无水乙醇进行减压蒸馏,将多余的氯化氢除去,接着将溶液浓缩至合适的体积,用干燥无水的乙醚沉淀得到脯氨酸乙酯盐酸盐。 Add 20 g of proline to 300 mL of absolute ethanol, pass in dry hydrogen chloride gas under stirring until saturated, then add absolute ethanol for vacuum distillation to remove excess hydrogen chloride, and then concentrate the solution to a suitable volume, and precipitated with dry anhydrous ether to obtain proline ethyl ester hydrochloride.

步骤3:合成以酰胺键连接的PEG-二脯氨酸缀合物: Step 3: Synthesis of PEG-diproline conjugates linked by amide bonds:

取10 g(0.5 mmol)步骤(1)中制备的CM-PEG二酸溶于40 mL干燥的二氯甲烷中,然后依次加入2 mmol的二环己基碳二亚胺(DCC)、2 mmol的脯氨酸乙酯盐酸盐,然后用三乙胺将溶液的pH值调节到8,搅拌反应过夜,过滤除去沉淀后,加入无水乙醚沉淀产物,将产物干燥后溶于去离子水,加入0.1 mol/L氢氧化钠溶液调节pH至11,然后用草酸将溶液pH调节到3,用氯仿萃取溶液三次,合并萃取液用无水硫酸钠干燥,溶液浓缩后再用无水乙醚沉淀得到分子量为20000 Da的PEG-二脯氨酸。 Take 10 g (0.5 mmol) of the CM-PEG diacid prepared in step (1) and dissolve it in 40 mL of dry dichloromethane, then add 2 mmol of dicyclohexylcarbodiimide (DCC), 2 mmol of Proline ethyl ester hydrochloride, then adjust the pH value of the solution to 8 with triethylamine, stir the reaction overnight, filter to remove the precipitate, add anhydrous ether to precipitate the product, dry the product and dissolve it in deionized water, add Adjust the pH to 11 with 0.1 mol/L sodium hydroxide solution, then adjust the pH of the solution to 3 with oxalic acid, extract the solution three times with chloroform, dry the combined extracts with anhydrous sodium sulfate, concentrate the solution and then precipitate with anhydrous ether to obtain the molecular weight PEG-diproline of 20000 Da.

步骤4: Step 4:

取步骤(3)制备的分子量为20000 Da的PEG-二脯氨酸,溶于干燥精制的无水二氯甲烷中,加入3倍摩尔量的二环己基碳二亚胺(DCC)和3倍摩尔量的N-羟基丁二酰亚胺,室温搅拌反应24小时,停止反应滤除沉淀二环己基脲(DCU),溶液用无水乙醚沉淀得到产物分子量为20000 Da的PEG-二脯氨酸的N-羟基丁二酰亚胺酯。 Take the PEG-diproline with a molecular weight of 20000 Da prepared in step (3), dissolve it in dry and refined anhydrous dichloromethane, add 3 times the molar amount of dicyclohexylcarbodiimide (DCC) and 3 times Molar amount of N-hydroxysuccinimide, stirred at room temperature for 24 hours, stopped the reaction and filtered off the precipitated dicyclohexyl urea (DCU), and the solution was precipitated with anhydrous ether to obtain PEG-diproline with a molecular weight of 20000 Da of N-hydroxysuccinimide esters.

Claims (8)

1. terminal acid or active ester that connects the polyoxyethylene glycol of proline(Pro) is characterized in that structure is as follows:
R 1-(OCH 2CH 2) n-O-R 2
N=43 ~ 680 wherein;
R 1Can be CH 3-, also can be R 2
R 2Structure as follows:
Figure 688251DEST_PATH_IMAGE001
R 3Can be H-, also can be-N-succimide base.
2. end according to claim 1 connects active acid or the ester of the polyoxyethylene glycol of proline(Pro), it is characterized in that said acid or ester are:
Figure 425263DEST_PATH_IMAGE002
Figure 948648DEST_PATH_IMAGE003
Figure 433168DEST_PATH_IMAGE005
NHS represents N-maloyl imines herein.
3. the active acid of the polyoxyethylene glycol of terminal connection proline(Pro) according to claim 1 and 2 or the preparation method of ester comprise the steps:
(1) polyoxyethylene glycol is dissolved in the toluene, added the potassium tert.-butoxide back flow reaction 1 ~ 2 hour, added the ethyl bromoacetate back flow reaction 2 ~ 4 hours, then room temperature reaction is 18 ~ 24 hours, uses ether sedimentation after concentrating, and then acidifying of throw out basic hydrolysis obtains CM-PEG;
(2) hydrogen chloride gas is passed into the ethanol that contains proline(Pro) until saturated, then collect the ethyl prolinate hydrochloride;
(3) get the CM-PEG for preparing in the step (1) and be dissolved in methylene dichloride, then add successively dicyclohexylcarbodiimide, ethyl prolinate hydrochloride, then with triethylamine the pH value of solution is adjusted to 8 ~ 9, reacted 8 ~ 12 hours, filter, filtrate adds ether, the collecting precipitation product, with water-soluble after the product drying, add sodium hydroxide solution and regulate pH to 10 ~ 12, reacted 1 ~ 3 hour, then with oxalic acid pH value of solution is adjusted to 2 ~ 4, collect product, obtain the terminal polyethyleneglycol derivative that connects proline(Pro);
(4) product of getting step (3) is dissolved in methylene dichloride, add the dicyclohexylcarbodiimide of 1.5 ~ 3 times of molar weights and the N-maloyl imines of 1.5 ~ 3 times of molar weights, 10 ~ 30 ℃ of stirring reactions 20 ~ 28 hours are collected product, obtain the terminal Active Ester of Polyethyen Glycol that connects proline(Pro).
4. method according to claim 3 is characterized in that, proline(Pro) can be D type, L-type or racemic modification.
5. according to claim 3 or 4 described methods, it is characterized in that described polyoxyethylene glycol can be mono methoxy polyethylene glycol, also can be two hydroxyl polyoxyethylene glycol, the molecular weight of described polyoxyethylene glycol is 2000 ~ 30000 Da.
6. terminal connect the polyethylene active acid of proline(Pro) or the application of ester according to claim 1 and 2 is characterized in that, be used for being connected with protein or enzyme, preparation has protein or the enzyme that PEG modifies.
7. a claim 1 or the 2 described terminal polyethylene active acid of proline(Pro) or the binding substancess of ester and biologically active substance of connecting is characterized in that general structure is as follows:
Figure 708291DEST_PATH_IMAGE006
Wherein: n be 1 or 2, NH-Pro partly represent the amino sites of biologically active substance.
8. modifier according to claim 7 is characterized in that biologically active substance is selected from protein, enzyme, polypeptide, medicine, dyestuff, nucleosides, ester class or liposome.
CN2012104460857A 2012-11-09 2012-11-09 Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with proline Pending CN102964587A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012104460857A CN102964587A (en) 2012-11-09 2012-11-09 Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with proline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012104460857A CN102964587A (en) 2012-11-09 2012-11-09 Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with proline

Publications (1)

Publication Number Publication Date
CN102964587A true CN102964587A (en) 2013-03-13

Family

ID=47795040

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012104460857A Pending CN102964587A (en) 2012-11-09 2012-11-09 Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with proline

Country Status (1)

Country Link
CN (1) CN102964587A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965566A (en) * 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
CN1660920A (en) * 2005-02-01 2005-08-31 华东理工大学 Polyglycolic acid or active ester with ω-amino acid connected at the end, its preparation method and application
CN101870769A (en) * 2010-06-13 2010-10-27 河北科技大学 PEG, mPEG chemical modifier and method for preparing water-soluble resveratrol prodrug

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965566A (en) * 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
CN1660920A (en) * 2005-02-01 2005-08-31 华东理工大学 Polyglycolic acid or active ester with ω-amino acid connected at the end, its preparation method and application
CN101870769A (en) * 2010-06-13 2010-10-27 河北科技大学 PEG, mPEG chemical modifier and method for preparing water-soluble resveratrol prodrug

Similar Documents

Publication Publication Date Title
JPH08507549A (en) Water-soluble non-immunogenic polyamide crosslinker
CN1232567C (en) End-amino water-soluble ultrabranching polyamide and preparation process thereof
JPS61243026A (en) Method for manufacturing polymerizable drugs
WO2006088248A1 (en) Polyoxyalkylene derivative
CN111298132A (en) A kind of dendrimer gemcitabine self-assembled nano-prodrug and its preparation method and application
CN104926920A (en) Protein polypeptide drug N-terminal fixed-point polyethylene glycol modification method
JPH04501121A (en) New biologically active drugs/polymer derivatives and their production methods
CN102321239B (en) Preparation method of water-soluble toluylene compound prodrugs
WO2003059987A1 (en) Multidrop tree branching functional polyethylene glycol, the preparation method and the use of it
CN102643420B (en) Poly alkyl ether compound with strange end group and double functional groups and application thereof
CN109908084B (en) A kind of platinum-crosslinked camptothecin prodrug micelle nanomedicine and its preparation method and application
CN106188222A (en) A kind of double dipeptide structure supermolecular gel factor and preparation method thereof
CN110669810B (en) A method for enzymatically preparing lysine oligopeptide and its monomethoxypolyethylene glycol modification
CN102964588A (en) Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with aminophenyl propionic acid
CN100546656C (en) A kidney-targeted drug carrier and its prodrug, preparation method and application
CN102964587A (en) Preparation method and application of acid or active ester of polyethylene glycol with tail end connected with proline
CN1210310C (en) N-lactose acyl chitosan
CN111454457B (en) A kind of chiral peptide antibacterial polymer with dendrimer as side chain and preparation method thereof
CN105017522A (en) Polyethylene glycol-modified unnatural amino acid preparation method
CN101307018A (en) Diethylenetriaminepentaacetic acid carboxyl activated ester or analogue and its synthesis method and application
JP2008308690A (en) POLY (ETHYLENE GLYCOL) FUNCTIONAL DERIVATIVE AND METHOD FOR PRODUCING THE SAME
CN116178733B (en) Branched monodisperse PEG derivative based on trifunctional amino acid, preparation method and application
Huang et al. Synthesis of an ortho-phthalaldehyde-functionalized copolymer for rapid, chemoselective and efficient conjugation with native proteins under physiological conditions
US5124437A (en) Galactosamine substitute of poly-ω-substituted-L-glutamic acid (or aspartic acid)
CN117126397A (en) Synthesis method and application of protein-binding type precise polyethylene glycol

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130313